Herb Forest

Herb Forest (Beijing) Biotechnology Co., Ltd. is a Chinese biotechnology company specializing in the development and production of plant-derived recombinant proteins through synthetic biology. The company utilizes a proprietary plant-based expression platform, often referred to as a "plant bioreactor," to manufacture high-purity recombinant human collagen and other bioactive proteins. Their products primarily target the medical aesthetics, dermatology, and regenerative medicine sectors, offering a safer and more sustainable alternative to traditional animal-derived proteins by minimizing the risk of immunogenicity and pathogen transmission. Herb Forest's pipeline includes various types of recombinant human collagen aimed at skin repair, wound healing, and tissue engineering applications. The company has attracted significant venture capital interest, including investment from ZhenFund, to scale its manufacturing capabilities and expand its portfolio of bioactive ingredients.